Caracterización de una población pediátrica seguida en una clínica de anticoagulación

Cely, Cesar H.; Galindo-Coral, Stephania; Mueses, Carolina; Figueroa, Luis; Flórez, Liliana J.; Gómez-Mesa, Juan E..
Rev. colomb. cardiol ; 29(1): 64-69, ene.-feb. 2022. tab
Artículo en Español | LILACS-Express | ID: biblio-1376856

Documentos relacionados

  1. Building solutions for the safety of the patient with heart disease using warfarin: a qualitative study
  2. Experiencia de una clínica de anticoagulación
  3. Analysis of the quality of anticoagulation with vitamin K antagonists in three clinical scenarios in Mexico.
  4. Extending INR testing intervals in warfarin patients at a multi-center anticoagulation clinic.
  5. Elevated INR in a COVID-19 patient after concomitant administration of favipiravir and warfarin: A case report.
  6. Targeting factor XI and factor XIa to prevent thrombosis.
  7. Safety of Continuing Anticoagulation Prior to Cardiac Catheterization in Pediatric Patients: A Los Angeles Center Experience.
  8. [The current role of warfarin].
  9. New Internet-Based Warfarin Anticoagulation Management Approach After Mechanical Heart Valve Replacement: Prospective, Multicenter, Randomized Controlled Trial.
  10. Critical Appraisal on the Role of Warfarin in the Current Era.